[HTML][HTML] Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets

Á Nagy, A Lánczky, O Menyhárt, B Győrffy - Scientific reports, 2018 - nature.com
Multiple studies suggested using different miRNAs as biomarkers for prognosis of
hepatocellular carcinoma (HCC). We aimed to assemble a miRNA expression database …

[HTML][HTML] HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer

EC de Heer, M Jalving, AL Harris - The Journal of clinical …, 2020 - Am Soc Clin Investig
Hypoxia-inducible factors (HIFs) and the HIF-dependent cancer hallmarks angiogenesis and
metabolic rewiring are well-established drivers of breast cancer aggressiveness, therapy …

[HTML][HTML] Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

B Győrffy - Computational and structural biotechnology journal, 2021 - Elsevier
Introduction Extensive research is directed to uncover new biomarkers capable to stratify
breast cancer patients into clinically relevant cohorts. However, the overall performance …

Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis

RY Ebright, S Lee, BS Wittner, KL Niederhoffer… - Science, 2020 - science.org
Circulating tumor cells (CTCs) are shed into the bloodstream from primary tumors, but only a
small subset of these cells generates metastases. We conducted an in vivo genome-wide …

[HTML][HTML] Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients

AM Szász, A Lánczky, Á Nagy, S Förster, K Hark… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Results The entire database incorporates 1,065 gastric carcinoma samples, gene
expression data. Out of 29 established markers, higher expression of BECN1 (HR= 0.68, p …

Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers

OMT Pearce, RM Delaine-Smith, E Maniati, S Nichols… - Cancer discovery, 2018 - AACR
We have profiled, for the first time, an evolving human metastatic microenvironment by
measuring gene expression, matrisome proteomics, cytokine and chemokine levels …

Kinome-wide RNA interference screen reveals a role for PDK1 in acquired resistance to CDK4/6 inhibition in ER-positive breast cancer

VM Jansen, NE Bhola, JA Bauer, L Formisano, KM Lee… - Cancer research, 2017 - AACR
Acquired resistance to cyclin-dependent kinases 4 and 6 (CDK4/6) small-molecule inhibitors
in breast cancer arises through mechanisms that are yet uncharacterized. In this study, we …

ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis

SJ Chung, GP Nagaraju, A Nagalingam, N Muniraj… - Autophagy, 2017 - Taylor & Francis
ABSTRACT ADIPOQ/adiponectin, an adipocytokine secreted by adipocytes in the breast
tumor microenvironment, negatively regulates cancer cell growth hence increased levels of …

[HTML][HTML] Increased cholesterol biosynthesis is a key characteristic of breast cancer stem cells influencing patient outcome

S Ehmsen, MH Pedersen, G Wang, MG Terp… - Cell reports, 2019 - cell.com
Tumor eradication may be greatly improved by targeting cancer stem cells (CSCs), as they
exhibit resistance to conventional therapy. To gain insight into the unique biology of CSCs …

miR‐34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression

C Corcoran, S Rani, L O'Driscoll - The Prostate, 2014 - Wiley Online Library
BACKGROUND Docetaxel‐resistance limits successful treatment of castration resistant
prostate cancer. We previously demonstrated that extracellular vesicles (exosomes) may …